Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

Francis J. Giles, Elihu H. Estey, Guillermo Garcia‐Manero et al.|Cancer|2001

Cited by 280